Pivotal Therapeutics Inc.
PVTTF
OTC PK
| 09/30/2015 | 06/30/2015 | 03/31/2015 | 12/31/2014 | 09/30/2014 | |
|---|---|---|---|---|---|
| Revenue | 80.70K | -8.00K | 124.00K | 94.80K | 66.60K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 80.70K | -8.00K | 124.00K | 94.80K | 66.60K |
| Cost of Revenue | 10.60K | 17.90K | 15.70K | 290.40K | 10.10K |
| Gross Profit | 70.10K | -25.90K | 108.30K | -195.50K | 56.50K |
| SG&A Expenses | 398.10K | 485.20K | 535.80K | 714.30K | 782.60K |
| Depreciation & Amortization | 27.20K | 28.90K | 28.30K | 23.00K | 25.20K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 511.70K | 624.10K | 690.90K | 1.14M | 1.06M |
| Operating Income | -430.90K | -632.10K | -567.00K | -1.05M | -993.10K |
| Income Before Tax | -811.50K | -1.18M | -963.00K | 32.80K | -1.50M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -811.50K | -1.18M | -963.00K | 32.80K | -1.50M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -811.50K | -1.18M | -963.00K | 32.80K | -1.50M |
| EBIT | -430.90K | -632.10K | -567.00K | -1.05M | -993.10K |
| EBITDA | -403.70K | -603.20K | -538.70K | -1.03M | -967.90K |
| EPS Basic | -0.01 | -0.01 | -0.01 | 0.00 | -0.02 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | 0.00 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | 0.00 | -0.02 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | 0.00 | -0.01 |
| Average Basic Shares Outstanding | 95.07M | 95.01M | 93.71M | 92.86M | 91.92M |
| Average Diluted Shares Outstanding | 95.07M | 95.01M | 93.71M | 92.86M | 91.92M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |